Results 61 to 70 of about 5,298 (70)

A phase I study of intravenous TZT-1027 administered on day 1 and day 8 of a three-weekly cycle in combination with carboplatin given on day 1 alone in patients with advanced solid tumours

Annals of Oncology, 2006
Gerhardt Attard
exaly  

Synthesis of the fully functionalized nine-membered diyne core of the C-1027 chromophore

Tetrahedron Letters, 2004
Masayuki Inoue
exaly  

Protective effects of VGX-1027 in PM2.5-induced airway inflammation and bronchial hyperresponsiveness

European Journal of Pharmacology, 2019
Mengmeng Xu, Feng Li, Hai Zhang
exaly  

Antitumor Activity of TZT-1027, a Novel Doiastatin 10 Derivative

Japanese Journal of Cancer Research, 1997
exaly  

Complete genome sequence of Streptomyces globisporus C-1027, the producer of an enediyne antibiotic lidamycin

Journal of Biotechnology, 2016
Bin Hong
exaly  

Characterization of the Interaction of TZT-1027, a Potent Antitumor Agent, with Tubulin

Japanese Journal of Cancer Research, 2000
exaly  

TZT-1027, an Antimicrotubule Agent, Attacks Tumor Vasculature and Induces Tumor Cell Death

Japanese Journal of Cancer Research, 2000
exaly  

Effects of SGI-1027 on Formation and Elimination of PrPSc in Prion-Infected Cells

Molecular Biology, 2020
exaly  

Solution structures of C-1027 apoprotein and its complex with the aromatized chromophore

Journal of Molecular Biology, 2001
exaly  

New Synthetic Route to the Highly Strained Cores of C-1027 and Neocarzinostatin Chromophores

Synlett, 1998
exaly